A research paper published in the journal Cancer publishes the findings of research that examined the mental health and well-being of over 200 mothers with advanced cancer. The women all had at least one child under the age of 18, had metastatic cancer via Science Daily
The researchers found that for mothers with stage IV cancer, parenting concerns contributed to their psychological distress. Associated with lower quality of life; the women scored higher in both depression and anxiety than the general population in the United States. The scientists also found a mother’s emotional well-being (these participants’ scores were lower than in other people with cancer in the United States) was linked with whether she had talked with her children about her illness and concerns about how her illness will financially impact her children.
The news item is available from Science Daily
Cancer is a leading cause of death among women of parenting age in the United States. Women living with advanced or incurable cancer who have dependent children experience high rates of depression and anxiety as well as unique parenting challenges. To the authors’ knowledge, few studies to date have examined the parenting factors associated with health‐related quality of life (HRQOL) in women with advanced cancer.
The authors conducted a cross‐sectional, Web‐based survey of the psychosocial concerns of 224 women with a tumor‐node‐metastasis staging system of the AJCC stage IV solid tumor malignancy who had at least 1 child aged less than 18 years. Participants completed validated measures of HRQOL (Functional Assessment of Cancer Therapy–General [FACT‐G]); depression and anxiety symptom severity; functional status; parenting concerns; and investigator‐designed questions to assess demographic, communication, and parenting characteristics. Multiple linear regression models were estimated to identify factors associated with FACT‐G total and subscale scores.
The mean FACT‐G score was 66 (standard deviation, 16). The mean Emotional Well‐Being subscale scores were particularly low (13; standard deviation, 5). In multivariable linear regression models, parenting variables explained nearly 40% of the HRQOL model variance. In the fully adjusted model, parenting concerns and the absence of parental prognostic communication with children both were found to be significantly associated with HRQOL scores. For each 1‐point increase in parenting concern severity, FACT‐G scores decreased by 4 points (P equal to .003).
Women with metastatic cancer who are parents of dependent children are at risk of high psychological distress and low HRQOL. Parenting factors may have a negative influence on HRQOL in this patient population. Cancer 2018. © 2018 American Cancer Society.
Park, E. M, et al | Understanding health‐related quality of life in adult women with metastatic cancer who have dependent children |Cancer |ePub https://doi.org/10.1002/cncr.31330
The Mental Health Foundation | April 2018 | Supporting the emotional and mental health needs of people with cancer
The psychological impact of having cancer has been little researched. In response to this The Mental Health Foundation has conducted qualitative research with patients diagnosed with cancer in Scotland. Their research focused on the negative mental health impacts of cancer, how effective support can be delivered, the barriers to support and the unmet mental health support needs.
The interviews identified the post-treatment phase a an especially volatile time for mental wellbeing. To address the unmet need in terms of service provision for mental health during cancer and to strengthen existing programmes, they make the following recommendations:
- There needs to be greater awareness by all service providers of the mental health impacts of cancer and the need to support emotional wellbeing and mental health
- The right support needs to be given at the right time
- Tailored, person-centred support needs to be offered at all stages of the cancer journey
- There must be more collaboration and communication between service providers
- Improve signposting for mental wellbeing services
- Provide clearer and more co-ordinated support pathways after treatment
- Improve the provision of support across Scotland
- More research is needed into how best to tackle social deprivation and co-morbed health inequalities
- More research and awareness is needed to design cancer and wellbeing support services that engage BME communities
- Ensure all people with cancer have access to some level of tumour support (The Mental Health Foundation)
You can download the full document from The Mental Health Foundation
Previous studies have reported conflicting results on the association between schizophrenia and cancer mortality | The British Journal of Psychiatry
Aims: To summarise available evidence and quantify the association between schizophrenia and cancer mortality using meta-analysis.
Method: We systematically searched literature in the PubMed and Embase databases. Risk estimates and 95% confidence intervals reported in individual studies were pooled using the DerSimonian–Laird random-effects model.
Results: We included 19 studies in the meta-analysis. Among them, 15 studies reported standardised mortality ratios (SMRs) comparing patients with schizophrenia with the general population, and the pooled SMR was 1.40 (95% CI 1.29–1.52, P<0.001). The other four studies reported hazard ratios (HRs) comparing individuals with schizophrenia with those without schizophrenia; the pooled HR was 1.51 (95% CI 1.13–2.03, P = 0.006).
Conclusions: Patients with schizophrenia are at a significantly increased risk of cancer mortality compared with the general population or individuals without schizophrenia.
Full reference: Zhuo, C. et al. (2017) Cancer mortality in patients with schizophrenia: systematic review and meta-analysis. The British Journal of Psychiatry. Published online: 8 June 2017.
Howard Sharp, K.M. Cancer. Published online: 4 May 2017
Background: The medical traumatic stress model is commonly applied to childhood cancer, assuming that the diagnosis of cancer is a traumatic event. However, to the authors’ knowledge, little is known regarding what specifically children perceive as stressful about cancer or how it compares with other stressful events more often experienced by children.
Conclusions: Children do not necessarily view their cancer experience as their most stressful life event. The findings of the current study suggest that the diagnosis of cancer might be better viewed as a manageable stressor rather than a major trauma, and are consistent with the change in the fifth edition of the DSM to eliminate the diagnosis of a life-threatening illness as a qualifying trauma for PTSD.
Read the full abstract here
Liang, X. et al. Cancer | Published online: 7 April 2017
Background: Few previous studies investigating depression before the diagnosis of breast cancer and breast cancer–specific mortality have examined depression measured at more than 1 time point. This study investigated the effect of depression (combining depressive symptoms alone with antidepressant use) measured at 2 time points before the diagnosis of breast cancer on all-cause mortality and breast cancer–specific mortality among older postmenopausal women.
Conclusions: Women with newly developed depression before the diagnosis of breast cancer had a modestly but significantly increased risk for death from any cause and for death from breast cancer at a late stage.
Read the full abstract here
Grossert, A. et al. BMC Cancer. Published online: 3 November 2016
Background: Being diagnosed with cancer causes major psychological distress, yet the majority of newly diagnosed cancer patients lack psychological support. Internet interventions overcome many barriers for seeking face-to-face support and allow for independence in time and place. We assess efficacy and feasibility of the first web-based stress management intervention (STREAM: STREss-Aktiv-Mindern) for newly diagnosed, German-speaking cancer patients.
Methods/design: In a prospective, wait-list controlled trial 120 newly diagnosed cancer patients will be included within 12 weeks of starting anti-cancer treatment and randomized between an immediate (intervention group) or delayed (control group) 8-week, web-based intervention. The intervention consists of eight modules with weekly written feedback by a psychologist (“minimal-contact”) based on well-established stress management manuals including downloadable audio-files and exercises. The aim of this study is to evaluate efficacy in terms of improvement in quality of life (FACT-F), as well as decrease in anxiety and depression (HADS), as compared to patients in the wait-list control group. A sample size of 120 patients allows demonstrating a clinically relevant difference of nine points in the FACT score after the intervention (T2) with a two-sided alpha of 0.05 and 80 % power. As this is the first online stress management intervention for German-speaking cancer patients, more descriptive outcomes are equally important to further refine the group of patients with the largest potential for benefit who then will be targeted more specifically in future trials. These descriptive endpoints include: patients’ characteristics (type of cancer, type of treatment, socio-demographic factors), dropout rate and dropout reasons, adherence and satisfaction with the program.
Discussion: New technologies open new opportunities: minimal-contact psychological interventions are becoming standard of care in several psychological disorders, where their efficacy is often comparable to face-to-face interventions. With our study we open this field to the population of newly diagnosed cancer patients. We will not only assess clinical efficacy but also further refine the target population who has the most potential to benefit. An internet-based minimal-contact stress management program might be an attractive, time- and cost-effective way to effectively deliver psychological support to newly diagnosed cancer patients and an opportunity to include those who currently are not reached by conventional support.
Read the full article here
Björkhem-Bergman, L. & Bergman, P. (2016) BMJ Supportive & Palliative Care. 6:287-291
Vitamin D is a hormone that is synthesised in the skin in the presence of sunlight. Sufficient vitamin D levels are important—not only for a healthy skeleton—but also for a healthy immune system. Many patients with cancer have insufficient vitamin D levels, and low vitamin D levels are associated with increased ‘all-cause mortality’ and especially mortality due to cancer. Low vitamin D levels have also been associated with increased risk of infections, increased pain, depressive disorders and impaired quality of life.
We review the role of vitamin D in the immune system, in relation to cancer disease, pain and depression. We have recently performed an observational study in 100 patients with palliative cancer in Sweden. The main result was that low vitamin D levels were associated with higher opioid dose, that is, more pain. We also describe a case report where vitamin D supplementation resulted in radically decreased opioid dose, less pain and better well-being.
Vitamin D supplementation is not connected with any adverse side effects and is easy to administrate. Thus, we hypothesise that vitamin D-supplementation to patients with palliative cancer might be beneficial and could improve their well-being, decrease pain and reduce susceptibility to infections. However, more clinical studies in this field are needed before firm conclusions can be drawn.
Read the full article here